Bellerophon to present at the jefferies virtual healthcare conference

Warren, n.j., may 27, 2021 (globe newswire) -- bellerophon therapeutics, inc. (nasdaq: blph) (“bellerophon” or the “company”), a clinical-stage biotherapeutics company focused on developing treatments for cardiopulmonary diseases, today announced that fabian tenenbaum, chief executive officer, will present a corporate overview at the jefferies virtual healthcare conference, being held june 1-4, 2021.
BLPH Ratings Summary
BLPH Quant Ranking